{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:33:29Z","timestamp":1714523609067},"reference-count":0,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Pharmacol. Jpn.","Folia Pharmacologica Japonica"],"published-print":{"date-parts":[[2024,5,1]]},"DOI":"10.1254\/fpj.23112","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T22:16:18Z","timestamp":1714515378000},"page":"157-159","source":"Crossref","is-referenced-by-count":0,"title":["Clinical application and future perspectives of HIF-PH inhibitors","HIF-PH\u963b\u5bb3\u85ac\u306e\u81e8\u5e8a\u5fdc\u7528\u3068\u5c06\u6765\u5c55\u671b"],"prefix":"10.1254","volume":"159","author":[{"given":"Masaomi","family":"Nangaku","sequence":"first","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","container-title":["Folia Pharmacologica Japonica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/159\/3\/159_23112\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T22:16:19Z","timestamp":1714515379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/159\/3\/159_23112\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1254\/fpj.23112","relation":{},"ISSN":["0015-5691","1347-8397"],"issn-type":[{"value":"0015-5691","type":"print"},{"value":"1347-8397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"article-number":"23112"}}